An Observational Study on Epithelioid Sarcoma

Launched by ITALIAN SARCOMA GROUP · Mar 28, 2017

Keywords

ClinConnect Summary

This clinical trial is studying a rare type of cancer called Epithelioid Sarcoma (ES). The main goal of the study is to learn more about the people who are affected by this condition, including their experiences and how the disease impacts them. The trial is currently looking for participants, and it is open to individuals of all ages and genders who have been diagnosed with Epithelioid Sarcoma based on specific medical guidelines.

To be eligible for the study, participants must have a confirmed diagnosis of Epithelioid Sarcoma from a biopsy or surgical sample and need to provide consent to take part in the research. They should also be able to follow the study's treatment and follow-up plans. However, individuals who have had other types of cancer in the last five years (with some exceptions) or who may have difficulties in following the study requirements will not be eligible. Participants in this trial can expect to contribute valuable information that may help improve our understanding of Epithelioid Sarcoma and potentially lead to better care for future patients.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • 1. Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
• • 2. Signed informed consent
• • 3. Adequate patient compliance to treatment or follow up
• • 4. No age limit
• • Exclusion criteria
• • 1. Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
• • 2. Impossibility to ensure adequate compliance